144 related articles for article (PubMed ID: 19177695)
1. Safety assessment of cosmetics in Europe. Preface.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():XVII-XX. PubMed ID: 19177695
[No Abstract] [Full Text] [Related]
2. Cosmetic products and their current European regulatory framework.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():1-28. PubMed ID: 18806452
[No Abstract] [Full Text] [Related]
3. The 7th Amendment to the Cosmetics Directive.
Ruet Rossignol M
Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
[No Abstract] [Full Text] [Related]
4. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
Vinardell MP
Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
[TBL] [Abstract][Full Text] [Related]
5. Challenges related to cosmetic safety assessment in the EU.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():29-57. PubMed ID: 18806453
[No Abstract] [Full Text] [Related]
6. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
Rogiers V
Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
[No Abstract] [Full Text] [Related]
7. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
8. Safety data requirements for the purposes of the Cosmetics Directive.
Manou I; Eskes C; de Silva O; Renner G; Zuang V
Altern Lab Anim; 2005 Jul; 33 Suppl 1():21-6. PubMed ID: 16194138
[No Abstract] [Full Text] [Related]
9. The current status of alternative methods for cosmetics safety assessment in China.
Luo FY; Su Z; Wu J; Zhang FL; Xing SX; Wang GL; Lu Y
ALTEX; 2019; 36(1):136-139. PubMed ID: 30456413
[No Abstract] [Full Text] [Related]
10. Towards an integrated in vitro strategy for repeated dose toxicity testing.
Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
[No Abstract] [Full Text] [Related]
11. Acute toxicity.
Gribaldo L; Gennari A; Blackburn K; Clemedson C; Deguercy A; Meneguz A; Pfaller W; Ruhdel I
Altern Lab Anim; 2005 Jul; 33 Suppl 1():27-34. PubMed ID: 16194139
[No Abstract] [Full Text] [Related]
12. Illegal cosmetics on the EU market: a threat for human health?
Desmedt B; Courselle P; De Beer JO; Rogiers V; Deconinck E; De Paepe K
Arch Toxicol; 2014 Sep; 88(9):1765-6. PubMed ID: 25079448
[No Abstract] [Full Text] [Related]
13. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
14. Subacute and subchronic toxicity.
Prieto P; Clemedson C; Meneguz A; Pfaller W; Sauer UG; Westmoreland C
Altern Lab Anim; 2005 Jul; 33 Suppl 1():109-16. PubMed ID: 16194144
[No Abstract] [Full Text] [Related]
15. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
[TBL] [Abstract][Full Text] [Related]
16. Headlines of safety assessment of cosmetics in Europe and future perspectives.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():166-82. PubMed ID: 18806458
[No Abstract] [Full Text] [Related]
17. The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 March 2021, SCCS/1628/21.
;
Regul Toxicol Pharmacol; 2021 Dec; 127():105052. PubMed ID: 34653552
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicty and mutagenicity.
Maurici D; Aardema M; Corvi R; Kleber M; Krul C; Laurent C; Loprieno N; Pasanen M; Pfuhler S; Phillips B; Sabbioni E; Sanner T; Vanparys P
Altern Lab Anim; 2005 Jul; 33 Suppl 1():117-30. PubMed ID: 16194145
[No Abstract] [Full Text] [Related]
19. Opinion of the scientific committee on consumer safety (SCCS) - Final version of the opinion on Ethylzingerone - 'Hydroxyethoxyphenyl Butanone' (HEPB) - Cosmetics Europe No P98 - in cosmetic products.
; Bernauer U;
Regul Toxicol Pharmacol; 2017 Aug; 88():330-331. PubMed ID: 28487064
[No Abstract] [Full Text] [Related]
20. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
